logo

Diamedica Therapeutics Inc. (DMAC)



Trade DMAC now with
  Date
  Headline
8/6/2020 9:14:12 AM DiaMedica Reports Pricing Of $20 Mln Public Offering Of Common Shares
2/11/2020 7:18:30 AM DiaMedica Therapeutics Prices Public Offering Of 2.125 Mln At $4.00 Per Share
10/14/2019 8:11:51 AM DiaMedica Says FDA Accepts Phase II Clinical Trial Protocol For CKD
1/3/2019 7:37:47 AM DiaMedica Announces FDA Clearance Of IND Application To Study DM199 In Patients With Chronic Kidney Disease